Double Anti-angiogenic and Anti-inflammatory Protein Valpha Targeting VEGF-A and TNF-α in Retinopathy and Psoriasis

This publication has 45 references indexed in Scilit:

• Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis
  Proceedings of the National Academy of Sciences, 2009
• Toll-Like Receptor 4 Decoy, TOY, Attenuates Gram-Negative Bacterial Sepsis
  PLOS ONE, 2009
• Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
  The American Journal of Pathology, 2008
• Erythropoietin deficiency decreases vascular stability in mice
  Journal of Clinical Investigation, 2008
• Essential role of sphingosine 1–phosphate receptor 2 in pathological angiogenesis of the mouse retina
  Journal of Clinical Investigation, 2007
• Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
  Experimental Cell Research, 2006
• Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
  Nature Reviews Drug Discovery, 2004
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• Evolving concepts of rheumatoid arthritis
  Nature, 2003
• NF-κB at the crossroads of life and death
  Nature Immunology, 2002